Shilanski & Associates’s MetLife MET Stock Holding History

Shilanski & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18,001	Closed	-$1.08M	–	118
2021 Q2	$1.08M	Buy	+18,001	New	+$1.14M	0.51%	57

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Shilanski & Associates's MET Position: Q3 2021 in Review

Shilanski & Associates sold out of MetLife (MET) in Q3 2021, closing a stake of 18,001 shares — an estimated $1.08M sold.

Shilanski & Associates first reported a position in MET in Q2 2021 and held it in 1 quarter. The position peaked at $1.08M in Q2 2021. 1,105 funds tracked by Wall St. Rank hold MET as of Q3 2021.

Shilanski & Associates reported no remaining MetLife position as of Q3 2021 after selling out during the quarter.
Shilanski & Associates sold 18,001 MetLife shares in Q3 2021, an estimated $1.08M.
Shilanski & Associates first reported a position in MetLife in Q2 2021 and held it in 1 quarter.
Shilanski & Associates's MetLife position peaked at $1.08M in Q2 2021.
1,105 funds tracked by Wall St. Rank held MetLife as of Q3 2021.

Based on Shilanski & Associates's 13F filing for Q3 2021, filed 12 Oct 2021.